ASCO: Vepdegestrant Ups Survival in ER+, HER2− Advanced Breast Cancer With ESR1 Mutations
Progression-free survival longer with vepdegestrant than fulvestrant in subgroup with ESR1 mutations, but not in the overall population
Parents Appear Receptive to Children Receiving HPV Vaccine at 9 or 10 Years of...
Most pushback due to child expectations of vaccine-free visit at 9 years; discussions shorter since sexual activity not perceived as salient
FDA Approves Tryptyr Eye Drops for Dry Eye Disease
Tryptyr works by stimulating corneal sensory nerves to increase natural tear production
16 Updates, Four New Recommendations Issued for Management of Pediatric VTE
Direct oral anticoagulants suggested over standard of care anticoagulants for pediatric patients with venous thromboembolism
ASCO: Encorafenib + Cetuximab + Chemo Lengthens Survival in Metastatic CRC
Significantly longer progression-free and overall survival seen in patients with BRAF V600E mutations
FDA Chief: COVID Vaccine in Pregnancy Should Be Personal Choice
Clinical Guideline Issued for Statin Use in Persons With HIV
Statins recommended for persons with HIV with a 10-year ASCVD risk score of 5 percent or higher; favored for those with risk score <5 percent
ACP Issues Clinical Guideline for Statin Use in Persons With HIV
Statins recommended for persons with HIV with a 10-year ASCVD risk score of 5 percent or higher; favored for those with risk score <5 percent
U.S. Ends $600M Moderna Bird Flu Vaccine Contract
Low Alcohol Use Disorder Treatment Rates Seen in Cancer Survivors
One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent
